Health Agency

The Apollo Group has opened its new 250-bed tertiary care centre in Bangalore. As the second phase, another 400 beds would be added in the next year and half.

Ranbaxy Laboratories’ net profit doubled to Rs 520 crore in December 2006, spurred by US sales of its copy of Merck & Co’s cholesterol-lowering pill Zocor, with a 180-day exclusivity period.

On a standalone basis, Jubilant Organosys reported 47.4% increase in net profit for the quarter.

Apollo will develop a super speciality teaching hospital, research and treatment facility for AIMU.

The company plans to use the proceeds to fully repay its 1.15 billion dollar of secured term debt.